http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2294204-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2ac951e8db7573d0c9c71901f8f550c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_43655bb0fd5f3be6bc09f81fcf9745fa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_79c917752ff5a3983e2092b44144be0e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3ab42ccf0967b9c983abafac3177d1f1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e7f2eee8b105806cc9622112b0bc236b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_60293e6987994f360e01106f4bb5ee14
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-525
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-685
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-355
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-714
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-455
filingDate 2006-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2007-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0653ee3b259ed10c49b01f908acc747d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef260f4e3595ffe29c66c453a10e5dfc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f4bb76c26ff904f0349d914b8822df40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_886038c059df5cc80b19630d00c76a1c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c10c643eadbd781ad5f73857d8e93f2a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d539af3738ce3b70efc31f93ade7e732
publicationDate 2007-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2294204-C1
titleOfInvention Method for treatment of stomach and duodenum ulcerous disease
abstract FIELD: medicine, gastroenterology. n SUBSTANCE: invention relates to a method for treatment of stomach and duodenum ulcerous disease. Method involves administration of combination of conventional anti-chelicobacter agents and preparation livorin forte in the dose 1 capsule, 3 times per a day, during eating for 1 month in patients with nonexpressed painful syndrome and insignificant dyspeptic disorders. Method involves administration preparations essentiale forte in combination with α-tocopherol acetate simultaneously with anti-chelicobacter agents in patients with expressed painful syndrome accompanying with nausea and vomiting wherein esentiale forte is administrated in the dose 5 ml in autoblood medium by intravenous route for the first 10 days of treatment followed by dosing by 2 capsules, 3 times per a day, during eating for 20 days. Administration of α-tocopherol acetate is carried out firstly as intramuscular injections in the dose 1.0 ml of 30% solution for 10 days followed by oral dosing by 1 capsule containing 0.2 ml of 50% preparation solution, 3 times per 24 h for 20 days. Based on eradication therapy and correction of lipids metabolism proposed method provides improving regeneration and endogenous mechanisms for protection of gastroduodenal region mucosa tissue resulting to reducing healing time of ulcers. n EFFECT: improved and enhanced effectiveness of treatment method. n 2 ex
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2464986-C1
priorityDate 2006-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4594
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP07374
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9SR52
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419590338
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP0CS22
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID121931
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534740
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410634091
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID210
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415821845
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID84029
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ6A3P9
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407386600
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4173
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO00084
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419551942
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID210
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID92946
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCB9GCH9
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454630876
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO13465
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507912
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282411
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505994
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506650
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10101269
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCE0ZS48
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14720269
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID33613
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP0CS23
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14985
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86472
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415792140
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419552635
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP08298
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152743214

Total number of triples: 65.